Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients

Seizure

Volumn 18, Issue 9, 2009, Pages 634-638

  Brandt, Christian ^a,b   May, Theodor W ^b   Pohlmann Eden, Bernd ^d   Nieder, Esther ^a,b   Elsner, Heike ^c   Witte Boelt, Karin ^b   Schuermann, Inka ^b   Ebner, Alois ^a,b  

^a EPILEPSY CENTER BETHEL   (Germany)

^b Society for Epilepsy Research   (Germany)

^c Vocational Training Centre   (Germany)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antiepileptic drugs; Epilepsy; Pregabalin; Retention rate; Treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BROMIDE; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; ATAXIA; BURNING SENSATION; CLINICAL PRACTICE; COGNITIVE DEFECT; DATA ANALYSIS; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RETENTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; EPISTAXIS; FATIGUE; FOCAL EPILEPSY; FOLLOW UP; FOOT EDEMA; GASTROINTESTINAL SYMPTOM; GRAND MAL SEIZURE; HAIR LOSS; HAND EDEMA; HEADACHE; HUMAN; HYPERTHYROIDISM; INCREASED APPETITE; LEG EDEMA; MAJOR CLINICAL STUDY; MENTAL DISEASE; MYOCLONUS; NERVOUSNESS; PARESTHESIA; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMOTOR DISORDER; RECOMMENDED DRUG DOSE; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN MANIFESTATION; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; URINARY URGENCY; URINE INCONTINENCE; VISUAL DISORDER; WEIGHT GAIN; XEROSTOMIA; ADOLESCENT; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; YOUNG ADULT;

EID: 73349106863     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.07.005     Document Type: Article

References (15)

1. Taylor C.P., Angelotti T., and Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73 February (2) (2007) 137-150
2. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., and Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60 May (10) (2003) 1631-1637
3. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 January (1) (2004) 20-27
4. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., and Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 February (3) (2005) 475-480
5. Elger C.E., Brodie M.J., Anhut H., Lee C.M., and Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 December (12) (2005) 1926-1936
6. Ben-Menachem E. Data from regulatory studies: what do they tell? What don't they tell?. Acta Neurol Scand Suppl 181 (2005) 21-25
7. Sander J.W. New antiepileptic drugs in practice-how do they perform in the real world?. Acta Neurol Scand Suppl 181 (2005) 26-29
8. Depondt C., Yuen A.W., Bell G.S., Mitchell T., Koepp M.J., Duncan J.S., et al. The long term retention of levetiracetam in a large cohort of patients with epilepsy. J Neurol Neurosurg Psychiatry 77 January (1) (2006) 101-103
9. Peltola J., Peltola M., Auvinen A., Raitanen J., Fallah M., and Keranen T. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study. Acta Neurol Scand June (2008)
10. Lozsadi D., Hemming K., and Marson A.G. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 1 (2008) CD005612
11. Bauer Jr. A. Pregabalin zur Kombinationsbehandlung von fokalen Epilepsien - Analyse des Behandlungsverlaufs von 103 Patienten. Akt Neurol 33 8 (2006) 439-441
12. Huber B., Bocchicchio M., Feuerbaum E., May T., Meinert T., Robertson E., et al. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability. Epilepsy Behav 13 August (2) (2008) 397-401
13. Ryvlin P. Defining success in clinical trials-profiling pregabalin, the newest AED. Eur J Neurol 12 November (Suppl. (4)) (2005) 12-21
14. Carreno M., Maestro I., Molins A., Donaire A., Falip M., Becerra J.L., et al. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure 16 December (8) (2007) 709-712
15. Valentin A., Moran N., Hadden R., Oakes A., Elwes R., Delamont R., et al. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England. Seizure February (2009)